20,300€
15,34%
Echtzeit-Aktienkurs Stevanato Group S.P.A.
Bid:
Ask:
Echtzeit-Chart der Stevanato Group S.P.A. Aktie
Börsenkurse Stevanato Group S.P.A.
| USA | - | - | - | - | 19,380$ | -1,07% |
| Lang & Schwarz | - | - | - | - | 20,300€ | 13,09% |
| Börse Stuttgart | - | - | - | - | 20,300€ | 13,73% |
| Echtzeit Euro | - | - | - | - | 20,300€ | 15,34% |
| Börse Frankfurt | - | - | - | - | 20,300€ | 15,34% |
| New York | - | - | - | - | 22,170$ | 14,40% |
| Tradegate | - | - | - | - | 20,300€ | 13,09% |
| gettex | - | - | - | - | 20,300€ | 13,73% |
Fundamentaldaten der Stevanato Group S.P.A. Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2023 [USD] | 1,17 Mrd. | 204,93 Mio. | 157,44 Mio. | 0,59 | 0,28% | 34,18 | 4,59 |
| 2022 [USD] | 1,03 Mrd. | 197,21 Mio. | 150,13 Mio. | 0,57 | 0,28% | 35,80 | 5,20 |
| 2021 [USD] | 997,50 Mio. | 195,18 Mio. | 158,76 Mio. | 0,60 | 0,25% | 33,83 | 5,39 |
| 2020 [USD] | 754,71 Mio. | 109,65 Mio. | 89,50 Mio. | 0,34 | - | 60,06 | 7,12 |
| 2019 [USD] | 600,52 Mio. | 61,53 Mio. | 43,88 Mio. | 0,17 | - | 122,29 | 8,95 |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. | |||||||
Profil der Stevanato Group S.P.A. Aktie
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.